Sarepta Therapeutics Company
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Estimated Revenue:
$50M to $100M
Technology:
Rare Genetic Disorders
Founded Date:
1980
Industry:
Gene Therapy